ST Huatong's newly established technology company includes Internet information service business. The enterprise search APP shows that recently, Shanghai Lingwu Technology Co., Ltd. was established, with the legal representative of Chen Qi and the registered capital of 1 million yuan. Its business scope includes: Internet information service; The second kind of value-added telecommunications services, etc. Enterprise equity penetration shows that the company is indirectly wholly-owned by ST Huatong.There will be another high-speed railway station in Xi 'an. According to the news of WeChat official account released by Xi 'an, on December 7th, with the completion of the last concrete pouring, it marked the completion of the underground structure construction of Gaoling Station of Xi 'an-Yan 'an high-speed railway, which was built by Shaanxi Company of Xicheng Passenger Dedicated Railway and Beijing Engineering Bureau Group of China Railway, and entered the construction stage of the above-ground main structure in an all-round way.The number of users of WeChat applet has reached 949 million. According to the latest data of QuestMobile, as of October this year, the cumulative number of users of WeChat applet has reached 949 million. On average, each user spends 1.7 hours a month using WeChat applets, while the average number of uses per month is close to 70, up by 15.1% and 5.2% respectively compared with the same period last year.
Bain raised its offer for Fuji Software to 9,600 yen per share.Microsoft is reported to have hired several DeepMind employees for the new AI health department. Mustafa Suleyman, the head of Microsoft consumer artificial intelligence and co-founder of DeepMind, is forming a new team focusing on consumer health. Dominic King, the former head of DeepMind health department, was hired as the vice president of Microsoft AI's new health team in London. He also poached DeepMind's clinical research scientist and Christopher Kelly, a neonatal intensive care doctor at Evelina Children's Hospital in London, and two other colleagues he worked with during DeepMind.The turnover of Oriental Wealth exceeded 14 billion yuan, down 1.64%.
The 2024 National Conference on Cultural and Tourism Project Construction was held. On December 10th, the 2024 National Conference on Cultural and Tourism Project Construction was held in Hefei, Anhui Province. The meeting demanded that we should accurately grasp the situation and opportunities faced by the construction of cultural and tourism projects, deepen the concept of integration, strengthen financial support, pay attention to scientific and technological empowerment, strengthen the guarantee of factors, strengthen the bottom line thinking, continue to promote the high-quality construction of cultural and tourism projects and the high-quality development of industries, and help to cultivate cultural tourism into a pillar industry. During the meeting, large-scale equipment renewal and consumer goods trade-in projects in the fields of culture and tourism were held, and representatives of relevant parties carried out policy propaganda and supply-demand docking exchanges around the "two new" work.Hanyu Pharmaceutical Co., Ltd. signed a strategic cooperation agreement with Longma Technology. Recently, Hanyu Biotechnology (Dali) Co., Ltd., a subsidiary of Hanyu Pharmaceutical Co., Ltd., signed a strategic cooperation agreement with Longma Technology Group. The two sides will cooperate in the medical application of industrial cannabis and drug research and development around drugs and cannabinoids.The global layout will further promote Sannuo Bio-CGM products to enter the European market. Recently, Sannuo Bio-CGM has reached a strategic cooperation with A.Menarini Diagnostics, a leading European medical diagnosis company, and signed an exclusive distribution agreement. The continuous glucose monitoring (CGM) products of Sannuo Bio will be launched in the European market in the form of joint brands of both parties. Sannuo Bio authorized A.Menarini Diagnostics to exclusively sell its CGM products in more than 20 countries and regions in Europe. In the future, the latter will vigorously promote the access, promotion and sales of Sannuo Bio CGM products in the European medical insurance market. Sannuo Bio has been actively deploying its internationalization strategy since its listing, and its iCan CGM is the first continuous glucose monitoring product certified by CE MDR in China. At present, Europe is the second largest market for CGM. In this cooperation, the two sides signed an exclusive distribution contract with considerable volume, which is expected to greatly accelerate the penetration and coverage of Sannuo Bio-CGM products in the European market.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide
12-14